Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
申请人:Glenmark Pharmaceuticals Ltd.
公开号:US07238725B2
公开(公告)日:2007-07-03
The present invention relates to novel tricyclic compounds useful for the treatment of inflammatory conditions, diseases of the central nervous and insulin resistant diabetes.
本发明涉及新型
三环化合物,用于治疗炎症状况、中枢神经疾病和
胰岛素抵抗性糖尿病。